Subscribe To
ADPT / Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q2 2022 Results - Earnings Call Transcript
Content Topics
Adaptive
Biotechnologies
Corporation
ADPT
Chad
Robins
2022
adpt
Results
Earnings
Transcript
Stock
ADPT News
By Seeking Alpha
September 27, 2023
Adaptive Biotechnologies: Not Quite There Yet, Growth Looks Priced
After a number of updates, there is no change in my investment rating for Adaptive Biotechnologies Corporation. Q2 FY'23 results showed mixed performa more_horizontal
By Zacks Investment Research
September 27, 2023
Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength?
Adaptive Biotechnologies (ADPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions mi more_horizontal
By InvestorPlace
August 28, 2023
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
Investing in biotech stocks is challenging even when you're investing in established companies with commercially available drugs and expansive pipelin more_horizontal
By 24/7 Wall Street
August 26, 2023
5 Stocks Wall Street and ARK's Cathie Wood Love Are Trading Under $10 With Huge Upside Potential
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in th more_horizontal
By Zacks Investment Research
August 2, 2023
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.33 per share in line with the Zacks Consensus Estimate. This compares to loss of more_horizontal
By Zacks Investment Research
July 26, 2023
Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Adaptive Biotechnologies (ADPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prep more_horizontal
By 24/7 Wall Street
July 8, 2023
5 Sizzling ‘Strong Buy' Stocks Under $10, and ARK's Cathie Wood Loves 3 of Them
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in th more_horizontal
By Seeking Alpha
July 7, 2023
Adaptive Biotechnologies: Getting Closer To The 'Buy Zone'
Shares of diagnostics and drug discovery concern Adaptive Biotechnologies Corporation have crashed over 90% as the commercial-stage concern struggles more_horizontal